We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · April 10, 2022

Benefit and Toxicity to PD-1 Blockade Varies by Ethnicity in Patients With Advanced Melanoma

The British Journal of Dermatology

 

Additional Info

The British Journal of Dermatology
Benefit and Toxicity to PD-1 Blockade Varies by Ethnicity in Patients with Advanced Melanoma: An International Multicenter Observational Study
Br J Dermatol 2022 Mar 16;[EPub Ahead of Print], X Bai, AN Shoushtari, A Betof Warner, L Si, B Tang, C Cui, X Yang, X Wei, HT Quach, CG Cann, MZ Zhang, L Pallan, C Harvey, MS Kim, G Kasumova, T Sharova, JV Cohen, DP Lawrence, C Freedman, RM Fadden, KM Rubin, DT Frederick, KT Flaherty, GV Long, AM Menzies, RJ Sullivan, GM Boland, DB Johnson, J Guo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading